NASDAQ
OrthoPediatrics Corp. (KIDS)
♥ 646 Thanks from members
OrthoPediatrics (KIDS) demonstrates strong operational momentum following record Q2 2026 financial results, driven by double-digit revenue growth, expanding gross margins, and surging adoption of new 'super cycle' product lines.